RxDoctor Payments Data

Kathryn Fordham

Family · Nashville, TNNPI 1164659512

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 128 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by AbbVie at 24.9% of the total. Reporting peaked in 2022 at $1,132 and has fallen 90.4% since, to $109 in 2025.

$2,362in general payments, 2019–2025

Across 128 payments — averaging $18.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$589
  • Novo Nordisk$496
  • Lilly USA, LLC$143
  • Biohaven Pharmaceuticals, Inc.$103
  • Eisai Inc.$91
  • Amgen$83
  • plus $856 from 25 others

What the payments were for

  • Food & beverage$2,362100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,362 in reported general payments places this provider in the 80th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee →

Other family in Nashville

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →